-
841por Haggenburg, Sabine, Garcia Garrido, Hannah M., Kant, Iris M. J., Van der Straaten, Hanneke M., De Boer, Fransien, Kersting, Sabina, Issa, Djamila, Te Raa, Doreen, Visser, Hein P. J., Kater, Arnon P., Goorhuis, Abraham, De Heer, Koen“…Patients with Chronic Lymphocytic Leukemia (CLL) have a 29- to 36-fold increased risk of invasive pneumococcal disease (IPD) compared to healthy adults. Therefore, most guidelines recommend vaccination with the 13-valent pneumococcal conjugated vaccine (PCV13) followed 2 months later by the 23-valent polysaccharide vaccine (PPSV23). …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
842por Ogunniyi, Abiodun D., Nguyen, Hang Thi, Hansford, Karl A., Cooper, Matthew A., Trott, Darren J., Blaskovich, Mark A. T.“…Bacteremic Streptococcus pneumoniae pneumonia is one of the most severe forms of invasive pneumococcal disease (IPD) and with particularly high case-fatality rates among the elderly and individuals with comorbidities, exacerbated by rising antibiotic resistance and time to initiation of therapy. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
843por Wolf, Asia-Sophia, Mitsi, Elena, Jones, Scott, Jochems, Simon P., Roalfe, Lucy, Thindwa, Deus, Meiring, James E., Msefula, Jacquline, Bonomali, Farouck, Makhaza Jere, Tikhala, Mbewe, Maurice, Collins, Andrea M., Gordon, Stephen B., Gordon, Melita A., Ferreira, Daniela M., French, Neil, Goldblatt, David, Heyderman, Robert S., Swarthout, Todd D.“…Childhood pneumococcal conjugate vaccine (PCV) protects against invasive pneumococcal disease caused by vaccine-serotype (VT) Streptococcus pneumoniae by generating opsonophagocytic anti-capsular antibodies, but how vaccination protects against and reduces VT carriage is less well understood. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
844por Van Goethem, Sam, Van Lint, Philippe, Willems, Philippe, Van Herendael, Bruno, Hoet, Katrien“…Respiratory pneumococcal PCR has a high negative predictive value for pneumococcal disease but the positive predictive value is low.…”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
845por Capeding, Maria Z Rosario, Puumalainen, Taneli, Gepanayao, Connie P, Käyhty, Helena, Lucero, Marilla G, Nohynek, Hanna“…BACKGROUND: An 11-valent pneumococcal conjugate vaccine could provide significantly larger reduction in pneumococcal disease burden than the currently available 7-valent vaccine formulation in many countries. …”
Publicado 2003
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
846Publicado 1994“…These studies confirm previous PspA immunization studies showing cross-protection against heterologous serotypes of S. pneumoniae and demonstrate a potential for rBCG-based PspA vaccines to elicit protective humoral responses against pneumococcal disease in humans.…”
Enlace del recurso
Enlace del recurso
Texto -
847por Rubin, Jaime L, McGarry, Lisa J, Klugman, Keith P, Strutton, David R, Gilmore, Kristen E, Weinstein, Milton C“…METHODS: A decision-analytic model was constructed to evaluate the impact of 7-valent pneumococcal conjugate vaccine (PCV7) on pneumococcal disease incidence and mortality during a typical influenza season (13/100) and a severe influenza pandemic (30/100). …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
848por Everett, Dean B., Mukaka, Mavuto, Denis, Brigitte, Gordon, Stephen B., Carrol, Enitan D., van Oosterhout, Joep J., Molyneux, Elizabeth M., Molyneux, Malcolm, French, Neil, Heyderman, Robert S.“…OBJECTIVE: To document trends in invasive pneumococcal disease (IPD) in a central hospital in Malawi during the period of national scale-up of antiretroviral therapy (ART) and cotrimoxazole prophylaxis. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
849por Elberse, Karin E. M., Nunes, Sónia, Sá-Leão, Raquel, van der Heide, Han G. J., Schouls, Leo M.“…In the era of pneumococcal conjugate vaccines, surveillance of pneumococcal disease and carriage remains of utmost importance as important changes may occur in the population. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
850por Azzari, Chiara, Cortimiglia, Martina, Moriondo, Maria, Canessa, Clementina, Lippi, Francesca, Ghiori, Federica, Becciolini, Laura, de Martino, Maurizio, Resti, Massimo“…The diagnosis of invasive pneumococcal disease (IPD) is currently based on culture methods, which lack sensitivity, especially after antibiotic therapy. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
851por Sanchez, Carlos J., Kumar, Nikhil, Lizcano, Anel, Shivshankar, Pooja, Dunning Hotopp, Julie C., Jorgensen, James H., Tettelin, Hervé, Orihuela, Carlos J.“…It is unclear whether Streptococcus pneumoniae in biofilms are virulent and contribute to development of invasive pneumococcal disease (IPD). Using electron microscopy we confirmed the development of mature pneumococcal biofilms in a continuous-flow-through line model and determined that biofilm formation occurred in discrete stages with mature biofilms composed primarily of dead pneumococci. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
852por Selva, Laura, Ciruela, Pilar, Blanchette, Krystle, del Amo, Eva, Pallares, Roman, Orihuela, Carlos J., Muñoz-Almagro, Carmen“…The objective of this study was to determine the distribution and clonal type variability of three potential vaccine antigens: Pneumococcal serine-rich repeat protein (PsrP), Pilus-1, and Pneumococcal choline binding protein A (PcpA) among pneumococcal isolates from children with invasive pneumococcal disease and healthy nasopharyngeal carriers. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
853por Sanvictores, Diozele Hazel M, Lucero, Marilla G, Nohynek, Hanna, Tallo, Veronica L, Tanskanen, Antti, Nillos, Leilani T, Williams, Gail“…Clinical data from 12,194 children who were given either study vaccine or placebo was collected from birth up to two years of age for the occurrence of radiologically proven pneumonia as the primary endpoint, and for clinical pneumonia and invasive pneumococcal disease as the secondary endpoints. Several tertiary endpoints were also explored. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
854“…This low level of priority was supported by the fact that the GPs rarely ever experienced a case of a severe pneumococcal disease in their daily work. Furthermore, perceived insufficient evidence resulting from existing epidemiologic data and clinical trials enhanced the little attention given to the pneumococcal vaccination. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
855por Kesavadev, Jothydev, Misra, Anoop, Das, Ashok Kumar, Saboo, Banshi, Basu, Debasis, Thomas, Nihal, Joshi, Shashank R., Unnikrishnan, A. G., Shankar, Arun, Krishnan, Gopika, Unnikrishnan, Ranjit, Mohan, Viswanathan“…Hospitalization and death due to pneumococcal disease and influenza are higher in diabetes patients. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
856“…BACKGROUND: The degree and time frame of indirect effects of vaccination (serotype replacement and herd immunity) are key determinants in assessing the net effectiveness of vaccination with pneumococcal conjugate vaccines (PCV) in control of pneumococcal disease. Using modelling, we aimed to quantify these effects and their dependence on coverage of vaccination and the vaccine's efficacy against susceptibility to pneumococcal carriage. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
857por Loman, Nicholas J., Gladstone, Rebecca A., Constantinidou, Chrystala, Tocheva, Anna S., Jefferies, Johanna M. C., Faust, Saul N., O’Connor, Leigh, Chan, Jacqueline, Pallen, Mark J., Clarke, Stuart C.“…A seven-valent conjugate vaccine (PCV7) is used to protect against invasive pneumococcal disease in children. Within three years of PCV7 introduction, we observed a fourfold increase in serotype 6C carriage, predominantly due to a single clone. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
858“…This is the first study to evaluate expression of virulence- and, colonization-related genes in the nasopharynx of healthy children and establishes the foundation for future gene expression studies during human pneumococcal disease.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
859por Kimaro Mlacha, Sheila Z, Romero-Steiner, Sandra, Dunning Hotopp, Julie C, Kumar, Nikhil, Ishmael, Nadeeza, Riley, David R, Farooq, Umar, Creasy, Todd H, Tallon, Luke J, Liu, Xinyue, Goldsmith, Cynthia S, Sampson, Jacquelyn, Carlone, George M, Hollingshead, Susan K, Scott, J Anthony G, Tettelin, Hervé“…Understanding the molecular interactions between the bacterium and the host will contribute to the control and prevention of pneumococcal disease. RESULTS: We used a combination of adherence assays, mutagenesis and functional genomics to identify novel factors involved in adherence. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
860por Molander, Viktor, Elisson, Camilla, Balaji, Veeraraghavan, Backhaus, Erik, John, James, Vargheese, Rosemol, Jayaraman, Ranjith, Andersson, Rune“…The aim of this study was to analyze the distribution of pneumococcal serotypes causing invasive pneumococcal disease (IPD), to survey the potential coverage of present and future vaccines, and to investigate differences between serotypes and groups of serotypes with regard to manifestation, case fatality rate, age, and other risk factors. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto